AYVAKIT
Live / Registered — Registered (as of 16 Nov 2021)
What this means for you
Registered since 16 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88478478
- Registration number
- 6563329
- Mark type
- Stylized text
- Filed
- 18 Jun 2019
- Published for opposition
- 15 Oct 2019
- Registered
- 16 Nov 2021
- Attorney of record
- Timothy H. Hiebert
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating cancer and mastocytosis
Owner
- Blueprint Medicines Corporation, Cambridge, MA, US
- Blueprint Medicines Corporation, Cambridge, MA, US
- Blueprint Medicines Corporation, Cambridge, MA, US
Prosecution history
- 16 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 15 Oct 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Oct 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Oct 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Sept 2021 — USE AMENDMENT FILED
- 30 Sept 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Sept 2021 — TEAS STATEMENT OF USE RECEIVED
- 14 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 May 2021 — SOU EXTENSION 3 GRANTED
- 12 May 2021 — SOU EXTENSION 3 FILED
- 12 May 2021 — SOU TEAS EXTENSION RECEIVED
- 12 Nov 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Nov 2020 — SOU EXTENSION 2 GRANTED
- 10 Nov 2020 — SOU EXTENSION 2 FILED
- 10 Nov 2020 — SOU TEAS EXTENSION RECEIVED